Xenon (** LENOXe (in some regions for anesthetic use) / Generic xenon gas **)
Other Medications
Description
Xenon is a noble gas that has anesthetic properties. It is being studied in clinical trials for various medical conditions. In the context of colorectal cancer, research is exploring its potential use, often in combination with other agents or techniques. The specific role of xenon in CRC treatment is still under investigation. The provided trial data (NCT01696630) focuses on xenon combined with intraoperative thoracic epidural analgesia, assessing safety in a small group of patients. The trial design involves sequential enrollment and safety monitoring by an independent board. The goal is to determine the safety and feasibility of this combination, potentially paving the way for further studies into its efficacy in specific patient populations or settings, although the specific application to colorectal cancer treatment is not the primary focus of this particular trial description.
Mechanism of Action
Xenon is an inert gas with anesthetic effects. Its mechanism of action as an anesthetic involves modulating the activity of certain ion channels in the brain, such as NMDA receptors and voltage-gated potassium channels. Research is exploring potential neuroprotective and anti-inflammatory effects of xenon, which might be relevant in certain medical contexts. However, its specific mechanism of action in the context of cancer treatment, if any, is not well-established and is an area of ongoing research. The trial mentioned (NCT01696630) does not detail a specific mechanism related to cancer treatment.
Side Effects
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.